Viewing nowCombinationRodista Tablet 80/5 mg (Telmisartan, Amlodipine Besylate)
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Medica Korea Co., Ltd.

MFDS item code 201901004 · Approved 2019.02.19 · Insurance code 646004650
Treatment of essential hypertension not controlled by monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by Amlodipine or Telmisartan alone. That is, it helps to effectively lower blood pressure and reduce the risk of complications from hypertension by administering both medications together. This improves cardiovascular health and enhances the patient's quality of life.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with an individual component, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when taking this medicine’). In elderly patients aged 75 years and older, amlodipine clearance is decreased; therefore, start treatment at a low dose and increase the dose gradually.
○ Pediatric patients: The safety and efficacy of this drug have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially during the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Patients with allergies to the components of this medication or specific liver, heart, or kidney diseases, as well as nursing women, should not take this medication. Caution should be used in patients with certain heart valve diseases or impaired liver function, gastrointestinal diseases, and renal vascular issues, and dosage should be adjusted under the guidance of a physician if necessary. Adverse effects like dizziness, edema, and hypotension may occur during the use of this medication, and in severe cases, fainting or kidney function abnormalities may occur, so any unusual symptoms should be immediately consulted with medical staff. This medication may interact with other drugs, so if you are currently taking any other medications, be sure to inform your doctor or pharmacist, especially when taking medications that increase potassium levels, as regular monitoring of blood potassium levels is recommended. Women who are pregnant or planning to become pregnant are advised to switch to other blood pressure medications with proven safety instead of this medication and should stop taking it immediately if pregnancy is confirmed. It is preferable not to use this medication during breastfeeding, and special caution is necessary for children and the elderly. In the case of overdose, symptoms such as hypotension, arrhythmias, and decreased kidney function may occur, so it is necessary to visit a medical institution immediately for appropriate treatment. This medication should be kept out of reach of children and it is recommended to open the packaging just before use. Caution should be exercised while driving or operating hazardous machinery as dizziness or drowsiness may occur during use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a dark container protected from light. Additionally, it is advisable to store it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication.
A white and light gray, double-convex oval tablet.
For domestic use - 30 tablets/PTP [30 tablets (10 tablets/Alu-Alu X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.